why choose us

First received: September 27, 2023

Clinical Trial: A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Respiratory Syncytial Virus

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Study to Evaluate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-Risk Adults

Brief Summary: The study is divided into 2 parts (Part A and Part B).Part A of the study will evaluate the safety and immune response to mRNA-1345 in high-risk adults aged ?18 to <60 years.Part B of the study will evaluate the safety and immune response to mRNA-1345 in adults who received solid organ transplant (SOT).

Read more